MoneyWorks4Me

Triochem Products Ltd (512101)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 512101 NSE: Pharmaceuticals & Drugs | Small Cap | Triochem Products Share Price

BSE Share Price
Not Listed

Triochem Products Ltd (512101)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 512101 NSE: Pharmaceuticals & Drugs | Small Cap | Triochem Products Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹17 / 17
TTM EPS
₹-36.1
TTM Sales
₹0 Cr.
Book Value per Share
₹180.1
P/E Ratio
0.00
Industry PE
53.2
Price to Book (P/B)
0.10
Price to Sales (P/S)
0.00
EV/EBITDA
10.69
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
46.46%
Return on Capital Employed (ROCE)
61.90%
Return on Assets (ROA)
45.90%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
68.65%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹4 Cr.
Equity
₹0.2 Cr.
Face Value
₹10
All Time Low / High
₹10.60 / 19.90

Triochem Products stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Triochem Products Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % 13.5%42.6%12.1%33%-2.9%14.4%-9.5%-10.1%-1.7%61.9%-
Value Creation
Index
0.02.0-0.11.4-1.20.0-1.7-1.7-1.1NA-

Growth Parameters

Sales 18.13512.42013.98.800000
Sales YoY Gr.-93.7%-64.7%62.2%-30.4%-36.7%-100%NANANA-
Adj EPS 19.993.129.5125.8-19.747.9-35.9-6.6-16.37.8-36.1
YoY Gr.-367.7%-68.3%325.8%-115.6%NA-174.9%NANANA-
BVPS (₹) 223.7327.9358.2497478532.5473.4596.7557.8842.8180.1
Adj Net
Profit
0.52.30.73.1-0.51.2-0.9-0.2-0.40.2-1
Cash Flow from Ops. -6.51.5-3.83.810.33.5-1-3.80.2-2.9-
Debt/CF from Ops. -0.41.6-1.60.7000000-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales -100%-100%NANA
Adj EPS -9.9%NANANA
BVPS15.9%12%21.2%51.1%
Share Price - - - -

Key Financial Parameters

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity %
9.433.88.629.4-49.5-7.1-1.2-2.81.1-7.1
Op. Profit
Mgn %
5.510.913.422.6-2.715.20000NAN
Net Profit
Mgn %
2.76.55.915.4-3.513.30000-INF
Debt to
Equity
0.50.30.70.2000000-
Working Cap
Days
93913422612347300000
Cash Conv.
Cycle
16522982281983400000

Valuation of Triochem Products - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Sales18.0634.9912.3520.0313.948.820000
Operating Expenses + 17.0631.1910.7015.5114.317.481.341.111.221.42
Manufacturing Costs0.981.341.260.860.760.510.610.400.410.55
Material Costs15.0528.628.3213.5712.586.30000.040
Employee Cost 0.670.730.720.820.670.500.520.470.590.53
Other Costs 0.360.500.400.260.300.180.200.240.170.34
Operating Profit 13.801.654.53-0.371.34-1.34-1.11-1.22-1.42
Operating Profit Margin (%) 5.5%10.9%13.4%22.6%-2.7%15.2%----
Other Income + 0.170.410.060.470.130.560.281.031.050.92
Exceptional Items 0000000-1.16011.17
Interest 0.070.400.460.270.210.020000.10
Depreciation 0.280.250.210.170.140.120.110.090.080.05
Profit Before Tax 0.823.571.044.55-0.581.76-1.17-1.33-0.2510.52
Tax 0.231.010.301.15-0.130.44-0.28-0.320.152.55
Profit After Tax 0.592.560.743.40-0.451.32-0.89-1.01-0.407.97
PAT Margin (%) 3.3%7.3%6.0%17.0%-3.2%15.0%----
Adjusted EPS (₹)23.9104.330.3138.9-18.254.0-36.1-41.4-16.3325.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 5.488.038.7812.1811.7113.0511.6014.6213.6720.65
Share Capital 0.250.250.250.250.250.250.250.250.250.25
Reserves 5.247.798.5311.9311.4712.8011.3514.3813.4220.40
Debt +2.862.285.792.50000000
Long Term Debt0000000000
Short Term Debt2.862.285.792.50000000
Minority Interest0000000000
Trade Payables1.660.720.340.740.320.170.180.130.160.03
Others Liabilities 0.280.770.241.200.030.11-0.22-0.160.030.20
Total Liabilities 10.2811.8015.1516.6212.0613.3311.5614.5913.8520.88

Fixed Assets

Net Fixed Assets +1.641.331.140.980.860.800.700.610.540
Gross Block5.111.841.851.851.881.931.931.931.930
Accumulated Depreciation3.480.510.710.881.011.131.231.311.390
CWIP 0000.030.0300000
Investments 00.090.090.080.0809.4211.0710.637.89
Inventories2.208.239.571.550.850.050.050.0500
Trade Receivables2.4503.3312.401.3900000
Cash Equivalents flag 0.400.920.250.558.2011.810.960.540.9111.73
Others Assets 3.601.230.771.020.650.670.432.311.781.26
Total Assets 10.2811.8015.1516.6212.0613.3311.5614.5913.8520.88
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity + -6.481.45-3.753.8210.253.47-1.03-3.760.20-2.87
PBT 0.833.571.044.55-0.581.76-1.17-1.33-0.2510.52
Adjustment 0.300.570.640.360.14-0.17-0.16-0.39-0.32-11.50
Changes in Working Capital -7.41-2.02-4.57-0.0711.032.27-0.06-1.970.770.09
Tax Paid -0.20-0.67-0.86-1.01-0.33-0.400.36-0.07-0.01-1.99
Cash Flow From Investing Activity + 3.71-0.010.02-0.0300.16-9.823.340.1713.70
Capex -0.03-0.03-0.01-0.03-0.02-0.0300011.72
Net Investments 3.71-00000-9.973.1401.80
Others 0.030.020.030.010.030.180.140.190.160.18
Cash Flow From Financing Activity + 2.80-0.923.06-3.49-2.61-0.020000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -0.05-0.35-0.45-0.20-0.11-0.020000
Dividend Paid 0000000000
Others 2.86-0.573.51-3.29-2.5000000
Net Cash Flow 0.030.52-0.670.307.643.61-10.85-0.420.3710.82
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)11.337.828.8432.48-3.7410.69-7.18-7.73-2.8346.46
ROCE (%)13.4842.5512.0532.99-2.8514.4-9.48-10.14-1.7361.9
Asset Turnover Ratio2.133.220.921.260.970.690000
PAT to CFO Conversion(x)-10.980.57-5.071.12N/A2.63N/AN/AN/A-0.36
Working Capital Days
Receivable Days48.50098.40143.30180.6000000
Inventory Days25.1053.50262.90101.4031.5018.800000
Payable Days41.4015.2023.3014.6015.4014.40001,1770

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Triochem Products Ltd FAQs

The current trading price of Triochem Products on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Triochem Products stood at ₹0.43 Cr

The latest P/E ratio of Triochem Products as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Triochem Products as of 31-Dec-1969 is 0.10.

The 52-week high of Triochem Products is ₹17.40 and the 52-week low is ₹17.40.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Triochem Products is ₹0.00 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Triochem Products Ltd is a average quality company.

No data found

No data found

About Triochem Products Ltd

Triochem Products Ltd, incorporated in 1972 and having its registered office address at Sambava Chambers,4th Floor,Sir P M Road Fort Mumbai,Maharashtra-400001, is in the Pharmaceuticals & Drugs  business.

The company offers contract manufacturing services to pharmaceutical companies located outside India. Alendronate sodium, iodinated glycerol, dinitro ortho toluamide, primidone, guinapyramine salts.

You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: